Navigation Links
NxStage(R) Reports Significant Interim FREEDOM Study Results
Date:10/27/2009

LAWRENCE, Mass., Oct. 27 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM study. The FREEDOM data will be presented in posters at the American Society of Nephrology (ASN) Renal Week 2009, from October 27th to November 1st in San Diego.

The FREEDOM analysis shows a significant reduction in the need for anti-hypertensive medications experienced by patients performing daily home hemodialysis (DHD) therapy with the NxStage System One(TM), and this reduction was maintained through the twelve month study period. These interim results from the FREEDOM study compared the number of anti-hypertensive medications (used to control blood pressure) that were prescribed at the patients' baseline (when they were on thrice-weekly, in-center hemodialysis), then at 4-months and 12-months after starting DHD. The study also looked at the number of patients who were not prescribed anti-hypertensive medications at those intervals. Key findings include:

  • A nearly 50% reduction in the average number of prescribed anti-hypertensive medications over 12 months;
  • 33% of patients completely discontinued anti-hypertensive medications; and,
  • 56% of patients experienced a 50% or greater decrease in anti-hypertensive medications.

Additional FREEDOM data demonstrates a 40% reduction in expected mortality of patients using daily home hemodialysis (DHD) therapy with the NxStage System One when compared to patients from the United States Renal Data System (USRDS). The Standardized Mortality Ratio (SMR), calculated from actual vs. expected deaths, was 0.6 for DHD patients compared to patients from the USRDS of similar age, gender, race and primary cause of ESRD.

"In an attempt to see
'/>"/>

SOURCE NxStage Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NxStage(R) to Report Third Quarter 2009 Financial Results
2. Boston Business Journal Names NxStage(R) Medical Third Fastest Growing Company in Massachusetts
3. NxStage(R) to Recognize Several Key Milestones at American Society of Nephrologys Renal Week 2007
4. Hospira Reports Third-Quarter 2009 Results
5. Peregrine Pharmaceuticals Reports 61% Objective Response Rate in 46-Patient Bavituximab Phase II Trial in Advanced Breast Cancer
6. Lilly Reports Solid Third-Quarter 2009 Results; Revises Full-Year 2009 EPS Guidance
7. Cell Therapeutics, Inc. Reports Outcome of Annual Meeting of Shareholders
8. Amylin Pharmaceuticals Reports Third Quarter Financial Results
9. Escalon(R) Reports Fourth Quarter and Fiscal 2009 Results
10. CareFusion Earns Top Ranking in MD Buyline and KLAS Reports
11. Misonix Reports Fourth Quarter and Fiscal Year 2009 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 2014 AARP Foundation today announced it has ... adults suffering from the severe cold weather that has ... are committed to helping those in need; so to ... will match dollar-for-dollar contributions up to $250,000, which could ... will be administered through AARP Foundation. ...
(Date:1/15/2014)... Texas , Jan. 15, 2014  Humberto C. ... Dermatology Achievement Award" from the Journal of Drugs ... Aesthetic & Clinical Conference (ODAC). The event is January 17-20, ... Florida . The ODAC ... on the practice of dermatology for clinical and aesthetic ...
(Date:1/15/2014)... -- MultiCell Technologies, Inc. (OTC Bulletin Board: ... concerning composition of matter, biological targets, mechanism of action, ... This patent application describes a novel ... (VSRNAs) which interfere with the basic homeostatic cellular processes ... than 10 bps, yet are surprisingly capable in their ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3
... (NASDAQ: PRXL ) announced today that it will ... FL.  James Winschel, Sr. Vice President and Chief Financial Officer ... on Tuesday, March 13, 2012. A live webcast ... section of PAREXEL,s website at www.PAREXEL.com in ...
... Angeion Corporation (NASDAQ: ANGN ) today announced that ... Board of Directors, effective March 1, 2012. ... Choice in Health Care at the Altarum Institute. She also ... School of Nursing at Indiana University/Purdue University at Indianapolis and ...
Cached Medicine Technology:PAREXEL International to Present at Barclays Capital Healthcare Conference 2Wendy D. Lynch, Ph.D., Joins Angeion's Board of Directors 2Wendy D. Lynch, Ph.D., Joins Angeion's Board of Directors 3Wendy D. Lynch, Ph.D., Joins Angeion's Board of Directors 4
(Date:4/16/2014)... SAN ANTONIO, Texas (April 16, 2014) A team ... The University of Texas Health Science Center at San ... the structure of a protein that helps a common ... Candida albicans causes yeast infections, diaper rashes ... pathogen to infect humans. It can also cause a ...
(Date:4/15/2014)... Scientists have solved a decades-old medical mystery and ... to fight invasive fungal infections, which kill about 1.5 million ... mechanism of action of amphotericin, an antifungal drug that has ... though it is nearly as toxic to human cells as ... report of the new findings appears in Nature ...
(Date:4/14/2014)... Henry Ford Hospital reached a medical milestone April ... using a novel way to access the heart. ... the United States performing the unique procedure called ... temporarily connecting major blood vessels. , Northern Michigan ... transcaval procedure on July 3, 2013 when traditional ...
(Date:4/14/2014)... John DeLuca, PhD, and Yael Goverover, PhD, OT, have ... persons with multiple sclerosis (MS) perform everyday life tasks. ... Measure Everyday Life Functional Activity in Multiple Sclerosis" provides ... senior VP of Research & Training at Kessler Foundation. ... is a visiting scientist at Kessler Foundation. She was ...
(Date:4/14/2014)... FRANCISCO, Calif.--True North Therapeutics, Inc., announced today a ... the destruction of human red blood cells exposed ... of autoimmune hemolytic anemia (AIHA). The article entitled ... prevents complement activation induced by cold agglutinin disease ... Blood earlier this month. TNT003 is ...
Breaking Medicine News(10 mins):Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 2Health News:Potent, puzzling and (now less) toxic: Team discovers how antifungal drug works 3Health News:Henry Ford Hospital hits new heart valve surgery milestone 2Health News:Ex vivo efficacy of C1s antibody as Complement inhibitor in cold agglutinin disease 2
... multiple low-energy treatments, combined with a plasma skin regeneration ... appearance, in record healing time. These multiple treatments have ... reduced healing times. ,"Plasma is a unique ... atoms to form an ionized gas," the authors write ...
... 27,000 women adds support to the view that high cholesterol ... even in healthy women with no history of heart disease ... importance of cholesterol levels as a risk factor for stroke, ... are otherwise healthy,” said study author Tobias Kurth, MD, ScD, ...
... over the influence of scantily clad dolls on young minds, ... one important reason for the rise of eating disorders, they ... voiced apprehension regarding the hype created by the media about ... which are known for their hour glass figures and revealing ...
... found evidence that a genetic tendency toward suicide has ... on chromosome 2. The same has been implicated in ... ,“We’re hoping our findings will eventually lead to tests ... suicide,” says Virginia Willour, Ph.D., an assistant professor in ...
... in women years in advance of a medical diagnosis ... ,Epidemiologists at the University at Buffalo in New ... diabetes found in the blood, such as markers of ... are present early on in women who eventually progress ...
... Otolaryngology-Head & Neck Surgery, chronic dizziness may be attributed// to ... study investigated 345 men and women who had suffered dizziness ... the age group of 15 to 89. It was found ... kind of anxiety disorders like migraine or a serious brain ...
Cached Medicine News:Health News:Multiple Low-energy Plasma Skin Treatments Beneficial in Reducing Facial Wrinkles 2Health News:Study Links Attempted Suicide With Genetic Evidence 2Health News:Study Links Attempted Suicide With Genetic Evidence 3Health News:Diabetes Risk Factors Develop Earlier in Women Than Men 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: